Join us at MassBio on April 7, 3-7PM
Derisked by Design. Built for the Clinic.
A preview of AI-enabled design, what drives pharma confidence, and what’s next across Alloy
Where integration becomes acceleration
Join Alloy Therapeutics for an invite-only R&D forum exploring how integrated discovery, AI-enabled design, and development strategy come together to accelerate programs toward the clinic. This focused afternoon will examine what drives pharma confidence today—and how to structure discovery efforts for translational and commercial success from the outset.
Through executive perspectives, real-world case studies, and candid discussion, you’ll gain practical insight into reducing downstream risk, aligning early decisions with clinical outcomes, and building programs that are partner-ready by design.
How early integration across discovery and development accelerates timelines and reduces downstream risk
How AI-enabled de novo design is informing smarter experimental decisions
Real-world examples of accelerating complex programs toward clinical advancement
What pharma expects from discovery-stage partnerships today
How discovery, engineering, delivery, and development readiness operate as a connected system
Sessions
Conversations that move science forward
We will open R&D Day with a brief look at Alloy’s evolution, from discrete discovery platforms to an integrated ecosystem built with the clinic in mind.
Founder & CEO, Alloy Therapeutics
A case study in disciplined integration. Learn how a challenging program advanced from early discovery into the clinic on a leading timeline—and how intentional design shaped clinical outcomes.
CSO and Co-Founder, Marea Therapeutics
A forward-looking view into Alloy’s evolving platform strategy across antibodies, bispecifics, AI-enabled design, and development-relevant innovation.
CEO, Antibody Powered Division at Alloy Therapeutics
CSO of Alloy Therapeutics
A candid discussion on what drives pharma confidence today—and how strong discovery collaborations evolve into clinical and commercial value.
President and Founding CEO, Normunity
Senior Director, Molecular Design & Development
Chief Partnership Officer, Alloy Therapeutics
An inside look at how AI is informing earlier, smarter, and more capital-efficient development strategies—positioning computational tools as risk-management infrastructure, not just discovery accelerators.
CSO of Insights Division
CEO of Insights Division
Connect with fellow attendees over drinks and hors d’oeuvres while discussing the ideas and breakthroughs shared throughout the afternoon. Dive deeper into the science, explore new opportunities, or simply unwind with colleagues from 5-7 p.m. as we close out R&D Day in an informal setting.
Senior Director of Data Science & Bioinformatics at Alloy Therapeutics
Senior Director, Machine Learning & Data Engineering at Alloy Therapetuics
Why Attend
For leaders thinking seriously about translational success
Hear directly from industry leaders advancing programs to the clinic
Understand how ecosystem-based collaboration changes partnership strategy
Gain practical insight into reducing
translational risk
Connect with a focused group of senior biotech and pharma peers
Join us at MassBio on April 7, 3-7PM
Derisked by Design.
Built for the Clinic.
Loading R&D Registration Form…
